申请人:Muto Susumu
公开号:US20050215645A1
公开(公告)日:2005-09-29
A medicament for enhancing an effect of a cancer therapy based on a mode of action of DNA injury, which comprises as an active ingredient a compound represented by the following general formula (I) or a salt thereof:
wherein one of R
1
and R
2
represents hydrogen atom and the other represents the formula —X-A wherein A represents hydrogen atom or an acyl group, X represents oxgen atom or NH; one of R
3
and R
4
represents hydrogen atom and the other represents the following formula:
wherein Y represents a sulfonyl group or a carbonyl group, R
5
represents a cyclic group, Z represents a single bond or a C
1
to C
4
alkylene group, R
6
represents hydrogen atom or a C
1
to C
6
alkyl group.
一种用于增强基于DNA损伤作用的癌症治疗效果的药物,其活性成分为以下一般式(I)或其盐表示的化合物:其中R1和R2中的一个代表氢原子,另一个代表式—X-A,其中A代表氢原子或酰基,X代表氧原子或NH;R3和R4中的一个代表氢原子,另一个代表以下式:其中Y代表磺酰基或羰基,R5代表环状基团,Z代表单键或C1到C4烷基烷基,R6代表氢原子或C1到C6烷基基团。